| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.02 |